Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bristol-Myers Squibb Company (BMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 78,629,680
  • Shares Outstanding, K 1,632,676
  • Annual Sales, $ 22,561 M
  • Annual Income, $ 4,920 M
  • 60-Month Beta 0.81
  • Price/Sales 3.54
  • Price/Cash Flow 11.16
  • Price/Book 5.65

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 1.14
  • Number of Estimates 1
  • High Estimate 1.14
  • Low Estimate 1.14
  • Prior Year 0.94
  • Growth Rate Est. (year over year) +21.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.15 +0.02%
on 03/22/19
54.38 -11.44%
on 03/05/19
-2.82 (-5.53%)
since 02/22/19
3-Month
44.30 +8.71%
on 01/03/19
54.38 -11.44%
on 03/05/19
-1.66 (-3.33%)
since 12/21/18
52-Week
44.30 +8.71%
on 01/03/19
64.05 -24.81%
on 03/23/18
-15.79 (-24.69%)
since 03/22/18

Most Recent Stories

More News
Why Bristol-Myers Squibb (BMY) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bristol-Myers Squibb (BMY) have what it takes? Let's find out.

BMY : 48.16 (-1.55%)
Next Support Level for Bristol-Myer Sqb (BMY) is $48.74

Shares of Bristol-Myer Sqb (NYSE:BMY) opened today below their pivot of $49.04 and have already reached the first level of support at $48.92. Analysts will be watching for a cross of the next downside...

BMY : 48.16 (-1.55%)
Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market

Merck's (MRK) Keytruda is rapidly gaining strength as a key contributor to the company's top line. The Keytruda development program is also progressing well.

AZN : 42.59 (-0.84%)
MRK : 82.29 (-0.80%)
PFE : 41.85 (-1.18%)
BMY : 48.16 (-1.55%)
Bristol-Myers' Celgene Buyout Still Uncertain Amid Opposition

The acquisition deal between Bristol-Myers and Celgene faces opposition from stakeholders of Bristol-Myers. The future of the deal depends on the outcome of the Special Meeting in April.

CELG : 88.15 (-1.65%)
MRK : 82.29 (-0.80%)
RHHBY : 33.7600 (-1.06%)
BMY : 48.16 (-1.55%)
Brain Cancer Study of Viral and Checkpoint Immunotherapy Initiates Accrual

Candel Therapeutics (a.k.a. Advantagene, Inc.) announced today the treatment of the first high grade glioma patients in a study of its Gene Mediated Cytotoxic Immunotherapy (GMCI(TM); aglatimagene besadenovec...

BMY : 48.16 (-1.55%)
Global Hodgkin's Lymphoma Drugs Market Outlook, 2019 to 2023 - Bristol-Myers Squibb Company, Merck & Co, Ono Pharmaceutical Co, Pfizer, and Seattle Genetics are Dominating - ResearchAndMarkets.com

The "Global Hodgkin's Lymphoma Drugs Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

MRK : 82.29 (-0.80%)
BMY : 48.16 (-1.55%)
OPHLF : 28.8300 (+1.55%)
Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know

Bristol-Myers Squibb (BMY) closed the most recent trading day at $49.21, moving -0.78% from the previous trading session.

BMY : 48.16 (-1.55%)
Look for Shares of Bristol-Myer Sqb to Potentially Rebound after Yesterday's 1.55% Sell Off

Bristol-Myer Sqb (NYSE:BMY) traded in a range yesterday that spanned from a low of $48.83 to a high of $49.59. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $48.84...

BMY : 48.16 (-1.55%)
SmarTrend Watching for Potential Rebound in Shares of Bristol-Myer Sqb After 1.55% Loss

Bristol-Myer Sqb (NYSE:BMY) traded in a range yesterday that spanned from a low of $48.83 to a high of $49.59. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $48.84...

BMY : 48.16 (-1.55%)
Pfizer/Merck KGaA End Bavencio+Talzenna Ovarian Cancer Study

Pfizer (PFE) and Merck KGaA terminate a late-stage study on Bavencio and its new PARP inhibitor, Talzenna. This is the third ovarian cancer study failure in less than six months.

MRK : 82.29 (-0.80%)
PFE : 41.85 (-1.18%)
MKGAF : 112.8500 (+0.09%)
BMY : 48.16 (-1.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade BMY with:

Business Summary

Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious...

See More

Key Turning Points

2nd Resistance Point 49.37
1st Resistance Point 48.76
Last Price 48.16
1st Support Level 47.85
2nd Support Level 47.55

See More

52-Week High 64.05
Fibonacci 61.8% 56.51
Fibonacci 50% 54.18
Fibonacci 38.2% 51.84
Last Price 48.16
52-Week Low 44.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar